JP2023515081A5 - - Google Patents

Info

Publication number
JP2023515081A5
JP2023515081A5 JP2022549924A JP2022549924A JP2023515081A5 JP 2023515081 A5 JP2023515081 A5 JP 2023515081A5 JP 2022549924 A JP2022549924 A JP 2022549924A JP 2022549924 A JP2022549924 A JP 2022549924A JP 2023515081 A5 JP2023515081 A5 JP 2023515081A5
Authority
JP
Japan
Prior art keywords
renal
pharmaceutical composition
composition according
injury
ch2x
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022549924A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023515081A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/019084 external-priority patent/WO2021168430A1/en
Publication of JP2023515081A publication Critical patent/JP2023515081A/ja
Publication of JP2023515081A5 publication Critical patent/JP2023515081A5/ja
Pending legal-status Critical Current

Links

JP2022549924A 2020-02-21 2021-02-22 腎損傷を治療するための組成物および方法 Pending JP2023515081A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202062979813P 2020-02-21 2020-02-21
US62/979,813 2020-02-21
PCT/US2021/019084 WO2021168430A1 (en) 2020-02-21 2021-02-22 Compositions and methods for treating renal injury

Publications (2)

Publication Number Publication Date
JP2023515081A JP2023515081A (ja) 2023-04-12
JP2023515081A5 true JP2023515081A5 (https=) 2024-03-01

Family

ID=77391654

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022549924A Pending JP2023515081A (ja) 2020-02-21 2021-02-22 腎損傷を治療するための組成物および方法

Country Status (7)

Country Link
EP (1) EP4106748A4 (https=)
JP (1) JP2023515081A (https=)
KR (1) KR20230011910A (https=)
AU (1) AU2021224268A1 (https=)
CA (1) CA3168728A1 (https=)
MX (1) MX2022010258A (https=)
WO (1) WO2021168430A1 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3548035A4 (en) 2016-11-30 2020-07-22 Case Western Reserve University COMBINATIONS OF 15-PGDH INHIBITORS WITH CORCOSTEROIDS AND / OR TNF INHIBITORS AND THEIR USES
JP2020514323A (ja) 2017-02-06 2020-05-21 ケース ウエスタン リザーブ ユニバーシティ 短鎖デヒドロゲナーゼ活性を調節する組成物と方法
KR102921276B1 (ko) 2018-11-21 2026-02-03 케이스 웨스턴 리저브 유니버시티 단쇄 데히드로게나아제 활성을 조절하는 조성물 및 방법
TW202419452A (zh) * 2022-11-11 2024-05-16 大陸商賽諾哈勃藥業(成都)有限公司 調控15-pgdh活性的化合物、其藥物組合物及其用途

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK2838533T3 (da) * 2012-04-16 2017-11-27 Univ Case Western Reserve Sammensætninger og fremgangsmåder til at modulere 15-pgdh-aktivitet
AU2014342811B2 (en) * 2013-10-15 2019-01-03 Board Of Regents Of The University Of Texas System Compositions and methods of modulating short-chain dehydrogenase activity
CN107921025A (zh) * 2015-03-08 2018-04-17 卡斯西部储备大学 用于治疗纤维症的短链脱氢酶活性的抑制剂
AU2016248080A1 (en) * 2015-04-14 2017-11-02 Board Of Regents Of The University Of Texas System Compositions and methods of modulating short-chain dehydrogenase activity
JP7426941B2 (ja) * 2018-04-04 2024-02-02 ケース ウエスタン リザーブ ユニバーシティ 腎傷害を治療するための組成物および方法

Similar Documents

Publication Publication Date Title
JP2023515081A5 (https=)
JP6124187B2 (ja) 一般的な抗炎症反応を与える複数のプロスタグランジン受容体において作用する化合物
US9603836B2 (en) Pyrrolidine-2, 5-dione derivatives, pharmaceutical compositions and methods for use as IDO1 inhibitors
JP2021519797A5 (https=)
RU2010117156A (ru) Гетероциклические соединения в качестве антагонистов crth2 рецептора
JP2009544602A5 (https=)
RU2011110908A (ru) Тиенопиримидины для фармацевтических композиций
US20240082194A1 (en) Preventive or therapeutic agent for inflammatory disorders and/or pain disorders
JP7153662B2 (ja) 薬理学的に活性な脂環式置換ピラゾロ[1,5-a]ピリミジン誘導体
AU2013209952B2 (en) New forms and salts of a dihydropyrrolo(1,2-c)imidazolyl aldosterone synthase or aromatase inhibitor
RU2005137155A (ru) Производные 9-азабицикло [3.3.1] нон-6-ена с гетероатомом на позиции 3 как ингибиторы ренина
US20240024297A1 (en) Compositions and methods for treating renal injury
WO2022120118A1 (en) Novel ripk1 kinase targeting protacs and methods of use thereof
KR20230011910A (ko) 신장 손상을 치료하기 위한 조성물 및 방법
JP2022514254A5 (https=)
RU2005137571A (ru) Новые производные диазабициклононена
JP6132851B2 (ja) 一般的な抗炎症反応を与える複数のプロスタグランジン受容体において作用する化合物
RU2005137174A (ru) Азабициклононеновые производные
JP2019537577A5 (https=)
WO2013103317A1 (en) Quinoline compounds which are anti-angiogenic integrin alpha5 betal inhibitors for use in the treatment of fibrosis or fibrosis-related diseases
US9090566B2 (en) Compounds acting at multiple prostaglandin receptors giving a general anti-inflammatory response
CA2694227A1 (en) Compositions and methods for treating or controlling anterior-segment inflammation
CN102186817A (zh) (羟烷基)吡咯衍生物的阻转异构体
CN107468685B (zh) 用于治疗高血压及心衰的药物组合物及复合物
JP2009029750A (ja) アリールプロパン誘導体を有効成分とする糖化最終産物形成阻害剤